Is Thymectomy Necessary During Parathyroidectomy for Secondary Hyperparathyroidism in Patients with End-stage Kidney Disease?

Overview

Journal Surgery

Specialty General Surgery

Date 2024 Oct 10

PMID 39389821

Authors

Joy Z Done

Andrew Gabrielson

Rachel Stemme

Darci C Foote

Jennine Weller

Jennyfer Villavicencio

Iyana Charles

Lilah F Morris-Wiseman

Aarti Mathur

Affiliations

Soon will be listed here.

Abstract

Background: Guidelines recommend thymectomy at the time of parathyroidectomy for secondary hyperparathyroidism to reduce the likelihood of persistent or recurrent disease. We sought to determine the frequency of thymectomy and explore its impact on recurrence of secondary hyperparathyroidism.

Methods: Using TriNetX, a multi-institutional electronic health record and insurance claims network, we conducted a retrospective cohort study of adults with secondary hyperparathyroidism who underwent parathyroidectomy with or without thymectomy from 2005 to 2023. Rates of thymectomy, repeat parathyroidectomy, and calcimimetic use were compared between cohorts. Recurrence was defined by parathyroid hormone ≥600 pg/mL, reoperation, or calcimimetic use. Current Procedural Terminology and SNOMED codes for parathyroidectomy did not distinguish between subtotal compared with total parathyroidectomy.

Results: Among 2,564 patients underwent surgery for secondary hyperparathyroidism, 2,272 (88.8%) underwent parathyroidectomy and 287 (11.2%) underwent parathyroidectomy + thymectomy. Rates of parathyroidectomy + thymectomydecreased over time, from 25.5% in 2005 to 10.1% in 2023. Preoperatively, there was no difference in mean preoperative parathyroid hormone levels, serum calcium or calcidiol, or cinacalcet use. Postoperatively, there was no difference in the mean parathyroid hormone level (183 pg/mL vs 180 pg/mL, P = .88), odds of calcimimetic use (odds ratio, 0.94, 95% confidence interval, 0.64-1.39), reoperation within 5 years postoperatively (odds ratio 0.72, 95% confidence interval 0.39-1.36), or rates of kidney transplantation (odds ratio 1.03, 95% confidence interval 0.67-1.60) between parathyroidectomy and parathyroidectomy + thymectomy groups.

Conclusion: Thymectomy is infrequently performed during parathyroidectomy for secondary hyperparathyroidism, and rates continue to decline. Although thymectomy at time of parathyroidectomy did not appear to decrease recurrence, future studies should include extent of parathyroidectomy to determine impact of thymectomy on recurrence in secondary hyperparathyroidism.

References

Mathur A, Ahn J, Sutton W, Zeiger M, Segev D, McAdams-DeMarco M . Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverage. Surgery. 2022; 172(1):118-126. PMC: 9233023. DOI: 10.1016/j.surg.2022.02.005. View

Dream S, Kuo L, Kuo J, Sprague S, Nwariaku F, Wolf M . The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Ann Surg. 2022; 276(3):e141-e176. DOI: 10.1097/SLA.0000000000005522. View

Okada M, Tominaga Y, Yamamoto T, Hiramitsu T, Narumi S, Watarai Y . Location Frequency of Missed Parathyroid Glands After Parathyroidectomy in Patients with Persistent or Recurrent Secondary Hyperparathyroidism. World J Surg. 2015; 40(3):595-9. DOI: 10.1007/s00268-015-3312-1. View

Riss P, Asari R, Scheuba C, Niederle B . Current trends in surgery for renal hyperparathyroidism (RHPT)--an international survey. Langenbecks Arch Surg. 2012; 398(1):121-30. DOI: 10.1007/s00423-012-1025-6. View

Sakman G, Parsak C, Balal M, Seydaoglu G, Eray I, Saritas G . Outcomes of Total Parathyroidectomy with Autotransplantation versus Subtotal Parathyroidectomy with Routine Addition of Thymectomy to both Groups: Single Center Experience of Secondary Hyperparathyroidism. Balkan Med J. 2014; 31(1):77-82. PMC: 4116002. DOI: 10.5152/balkanmedj.2014.9544. View

Uludag M, Unlu M, Kostek M, Caliskan O, Aygun N, Isgor A . Persistent and Recurrent Primary Hyperparathyroidism: Etiological Factors and Pre-Operative Evaluation. Sisli Etfal Hastan Tıp Bul. 2023; 57(1):1-17. PMC: 10098391. DOI: 10.14744/SEMB.2023.39260. View

Reitz 3rd R, Dreimiller A, Khil A, Horwitz E, McHenry C . Ectopic and supernumerary parathyroid glands in patients with refractory renal hyperparathyroidism. Surgery. 2020; 169(3):513-518. DOI: 10.1016/j.surg.2020.08.007. View

Kooshesh K, Foy B, Sykes D, Gustafsson K, Scadden D . Health Consequences of Thymus Removal in Adults. N Engl J Med. 2023; 389(5):406-417. PMC: 10557034. DOI: 10.1056/NEJMoa2302892. View

Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A . Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2010; 26(6):1948-55. PMC: 3107766. DOI: 10.1093/ndt/gfq219. View

10.

Baugh K, Yip L, Ramonell K, Carty S, McCoy K . Outcomes of subtotal parathyroidectomy for renal hyperparathyroidism. Surgery. 2023; 175(3):788-793. DOI: 10.1016/j.surg.2023.09.016. View

11.

Phitayakorn R, McHenry C . Incidence and location of ectopic abnormal parathyroid glands. Am J Surg. 2006; 191(3):418-23. DOI: 10.1016/j.amjsurg.2005.10.049. View

12.

Schlosser K, Bartsch D, Diener M, Seiler C, Bruckner T, Nies C . Total Parathyroidectomy With Routine Thymectomy and Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism: Results of a Nonconfirmatory Multicenter Prospective Randomized Controlled Pilot Trial. Ann Surg. 2016; 264(5):745-753. DOI: 10.1097/SLA.0000000000001875. View

13.

Palchuk M, London J, Perez-Rey D, Drebert Z, Winer-Jones J, Thompson C . A global federated real-world data and analytics platform for research. JAMIA Open. 2023; 6(2):ooad035. PMC: 10182857. DOI: 10.1093/jamiaopen/ooad035. View

14.

Abruzzo A, Gioviale M, Damiano G, Palumbo V, Buscemi S, Lo Monte G . Reoperation for persistent or recurrent secondary hyperparathyroidism. Acta Biomed. 2017; 88(3):325-328. PMC: 6142843. DOI: 10.23750/abm.v88i3.4722. View

15.

Coco M, Rush H . Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000; 36(6):1115-21. DOI: 10.1053/ajkd.2000.19812. View

16.

Gomes E, Nunes R, Lacativa P, Almeida M, Franco F, Leal C . Ectopic and extranumerary parathyroid glands location in patients with hyperparathyroidism secondary to end stage renal disease. Acta Cir Bras. 2007; 22(2):105-9. DOI: 10.1590/s0102-86502007000200005. View

17.

Aly A, Douglas M . Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg. 2003; 73(5):284-8. DOI: 10.1046/j.1445-2197.2003.t01-1-02620.x. View

18.

Steinl G, Kuo J . Surgical Management of Secondary Hyperparathyroidism. Kidney Int Rep. 2021; 6(2):254-264. PMC: 7879113. DOI: 10.1016/j.ekir.2020.11.023. View

19.

Schneider R, Bartsch D, Schlosser K . Relevance of bilateral cervical thymectomy in patients with renal hyperparathyroidism: analysis of 161 patients undergoing reoperative parathyroidectomy. World J Surg. 2013; 37(9):2155-61. DOI: 10.1007/s00268-013-2091-9. View

20.

Soares M, Cavalcanti G, Iwakura R, Lucca L, Romao E, de Freitas L . Analysis of the role of thyroidectomy and thymectomy in the surgical treatment of secondary hyperparathyroidism. Am J Otolaryngol. 2018; 40(1):67-69. DOI: 10.1016/j.amjoto.2018.10.010. View